ArticleClinical and translational science2025

Added Therapeutic Benefits of Top-Selling Drugs in Japan: A Cross-Sectional Study Using Health Technology Assessment.

Hayase Hakariya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.